MALVERN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company historically focused on developing a pipeline of novel...
MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
4 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
12 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
26 | -0.0966 | -39.9834437086 | 0.2416 | 0.2416 | 0.1314 | 798009 | 0.17651699 | CS |
52 | -0.03 | -17.1428571429 | 0.175 | 0.29 | 0.0853 | 1860380 | 0.18513219 | CS |
156 | -7.355 | -98.0666666667 | 7.5 | 8.51 | 0.0853 | 2103524 | 1.82426556 | CS |
260 | -12.355 | -98.84 | 12.5 | 19.5 | 0.0853 | 1340751 | 2.12123817 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.